TY - JOUR
T1 - Thrombotic thrombocytopenic purpura
T2 - 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research
AU - Sarode, Ravi
AU - Bandarenko, Nick
AU - Brecher, Mark E.
AU - Kiss, Joseph E.
AU - Marques, Marisa B.
AU - Szczepiorkowski, Zbigniew M.
AU - Winters, Jeffrey L.
PY - 2014/6
Y1 - 2014/6
N2 - The American Society for Apheresis (ASFA) conducted a 1 day consensus conference on Thrombotic Thrombocytopenic Purpura (TTP) during its annual meeting in Atlanta, GA, on April 10, 2012. The authors of this article, a subcommittee of ASFA's Clinical Applications Committee, developed several questions with regard to definitions, classification, pathophysiology, diagnosis, management, and future research in TTP. These questions were provided to the seven invited speakers who are the experts in the field of TTP. Two moderators conducted the proceedings of the conference which was attended by more than 100 participants. After each presentation, there was an open discussion that included moderator-selected written questions submitted by the audience. A medical writer-generated transcript of the proceedings as well as each presentation was made available to the authors. Each summary was reviewed and approved by the respective speaker before submission of this article. The subcommittee also developed seven key questions for blinded, electronic polling conducted by the moderators to generate a consensus amongst the speakers. This article includes these presentation summaries as well as results of the electronic poll.
AB - The American Society for Apheresis (ASFA) conducted a 1 day consensus conference on Thrombotic Thrombocytopenic Purpura (TTP) during its annual meeting in Atlanta, GA, on April 10, 2012. The authors of this article, a subcommittee of ASFA's Clinical Applications Committee, developed several questions with regard to definitions, classification, pathophysiology, diagnosis, management, and future research in TTP. These questions were provided to the seven invited speakers who are the experts in the field of TTP. Two moderators conducted the proceedings of the conference which was attended by more than 100 participants. After each presentation, there was an open discussion that included moderator-selected written questions submitted by the audience. A medical writer-generated transcript of the proceedings as well as each presentation was made available to the authors. Each summary was reviewed and approved by the respective speaker before submission of this article. The subcommittee also developed seven key questions for blinded, electronic polling conducted by the moderators to generate a consensus amongst the speakers. This article includes these presentation summaries as well as results of the electronic poll.
KW - ADAMTS13
KW - Upshaw Shulman Syndrome
KW - microangiopathic hemolytic anemia
KW - therapeutic plasma exchange
KW - thrombotic thrombocytopenic purpura
UR - http://www.scopus.com/inward/record.url?scp=84902529329&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902529329&partnerID=8YFLogxK
U2 - 10.1002/jca.21302
DO - 10.1002/jca.21302
M3 - Review article
C2 - 24136342
AN - SCOPUS:84902529329
SN - 0733-2459
VL - 29
SP - 148
EP - 167
JO - Journal of Clinical Apheresis
JF - Journal of Clinical Apheresis
IS - 3
ER -